{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:32:51Z","timestamp":1786717971871,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/ijo.ijo_958_16","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T11:42:43Z","timestamp":1489664563000},"page":"48","source":"Crossref","is-referenced-by-count":18,"title":["Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area"],"prefix":"10.4103","volume":"65","author":[{"given":"GamzeOzturk","family":"Karabulut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pelin","family":"Kaynak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Ozturker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korhan","family":"Fazil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OsmanBulut","family":"Ocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhittin","family":"Taskap\u0131l\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.202318-1","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.ajo.2005.06.057","article-title":"Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma","author":"Blasi","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.202318-2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/IOP.0b013e3181b8dd71","article-title":"Imiquimod 5% cream for the treatment of periocular basal cell carcinoma","author":"Carneiro","year":"2010","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"key-10.4103\/0301-4738.202318-3","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00417-007-0561-1","article-title":"Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: A 3-year follow-up study","author":"Choontanom","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.202318-4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/jop.2010.0030","article-title":"Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas","author":"Garcia-Martin","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.4103\/0301-4738.202318-5","doi-asserted-by":"crossref","unstructured":"Bath-Hextall F, Bong J, Perkins W, Williams H. Interventions for basal cell carcinoma of the skin: Systematic review. BMJ 2004;329:705.","DOI":"10.1136\/bmj.38219.515266.AE"},{"key":"key-10.4103\/0301-4738.202318-6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1755-3768.2007.00896.x","article-title":"Imiquimod in the treatment of eyelid basal cell carcinoma","author":"Lepp\u00e4l\u00e4","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"key-10.4103\/0301-4738.202318-7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1745-6215-11-42","article-title":"The SINS trial: A randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma","author":"Ozolins","year":"2010","journal-title":"Trials"},{"key":"key-10.4103\/0301-4738.202318-8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1442-9071.2006.01177.x","article-title":"Topical therapy with imiquimod for eyelid lesion","author":"Tsang","year":"2006","journal-title":"Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.202318-9","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1136\/bjo.2009.178202","article-title":"The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions","author":"Cannon","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.202318-10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00417-010-1526-3","article-title":"Long-term outcome after treatment with 5% topical imiquimod cream in patients with basal cell carcinoma of the eyelids","author":"Prokosch","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.202318-11","first-page":"35","article-title":"Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: A non-randomized trial","author":"de","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"key-10.4103\/0301-4738.202318-12","doi-asserted-by":"crossref","unstructured":"Tinelli M, Ozolins M, Bath-Hextall F, Williams HC. What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs. imiquimod? A discrete choice experiment survey from the SINS trial. BMC Dermatol 2012;12:19.","DOI":"10.1186\/1471-5945-12-19"},{"key":"key-10.4103\/0301-4738.202318-13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.iop.0000170421.07098.61","article-title":"Bowen disease of the eyelid successfully treated with imiquimod","author":"Brannan","year":"2005","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"key-10.4103\/0301-4738.202318-14","doi-asserted-by":"crossref","unstructured":"Costales-\u00c1lvarez C, \u00c1lvarez-Coronado M, Rozas-Reyes P, Gonz\u00e1lez-Rodr\u00edguez CM, Fern\u00e1ndez-Vega L. Topical imiquimod 5% as an alternative therapy in periocular basal cell carcinoma in two patients with surgical contraindication. Arch Soc Esp Oftalmol 2016. pii: S0365-669130123-X.","DOI":"10.1016\/j.oftale.2016.11.003"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:29:47Z","timestamp":1786714187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_958_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"alternative-id":["202318"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_958_16","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}